Establishment and Analysis of mice disrupted with DNAM-1 gene
DNAM-1基因破坏小鼠的建立及分析
基本信息
- 批准号:10833002
- 负责人:
- 金额:$ 1.86万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DNAM-1 is a signal transducing adhesion molecule involved in the cytolytic function mediated by CTL and NK cells. Cross-linking DNAM-1 with anti-DNAM-1 mAb induces cytolysis mediated by CTL and NK cells and also results in tyrosine phosphorylation of the DNAM-1 molecule. We studied regulation of DNAM-1-mediated signaling and adhesion. We report here that specific inhibitors of PKC activity prevented DNAM-1-mediated cytolytic activation of NK cells. Adhesion of DNAM-1 to its ligand does not require divalent cations, such as magnesium or calcium, and is regulated by PKC, as demonstrated by augmentation of DNAM-1 adhesion by PMA and inhibition by specific PKC inhibitors. Mutation of the putative PKC binding site in the cytoplasmic domain of DNAM-1 (SerィイD1329ィエD1 to PheィイD1329ィエD1) prevents ligand binding and PMA-induced serine phosphorylation of the DNAM-1 receptor. These results indicate that PKC phosphorylates SerィイD1329ィエD1 of DNAM-1 and plays a critical role for both DNAM-1 adhesion and signaling.Whereas ligation of DNAM-1 adhesion molecule triggers cytotoxicity mediated by normal NK and T cells, this function was defective in NK cell clones from leukocyte adhesion deficiency syndrome. However, genetic reconstitution of cell surface expression of LFA-1 restored the ability of DNAM-1 to initiate anti-DNAM-1 mAb induced cytotoxicity, indicating a functional relationship between DNAM-1 and LFA-1. Further studies demonstrated that LFA-1 physically associates with DNAM-1 in NK cells and anti-CD3 mAb stimulated T cells, for which serine phosphorylation of DNAM-1 plays a critical role. In addition, cross-linking of LFA-1 induces tyrosine phosphorylation of DNAM-1, for which the fyn protein tyrosine kinase is responsible. These results indicate that DNAM-1 is involved in the LFA-1-mediated intracellular signals.
DNAM-1是一种信号转导的粘合分子,涉及由CTL和NK细胞介导的细胞溶解功能。与抗DNAM-1 MAB的交联DNAM-1可诱导由CTL和NK细胞介导的胞溶性,并导致DNAM-1分子的酪氨酸磷酸化。我们研究了DNAM-1介导的信号传导和粘合剂的调节。我们在这里报告说,PKC活性的特异性抑制剂阻止了DNAM-1介导的NK细胞的溶细胞激活。 DNAM-1对配体的粘附不需要二价阳离子,例如镁或钙,并且受PKC的调节,如PMA增强DNAM-1粘合剂所证明的,而特定的PKC抑制剂抑制。 DNAM-1的细胞质结构域(Seri d1329i d1 to Phei D1329I D1)中推定的PKC结合位点的突变可防止配体结合和PMA诱导的DNAM-1受体的连续磷酸化。 These results indicate that PKC phosphorylates Seri D1329 D1 of DNAM-1 and plays a critical role for both DNAM-1 adhesive and signaling.Whereas ligation of DNAM-1 adhesive molecule triggers cytotoxicity mediated by normal NK and T cells, this function was defective in NK cell clones from leukocyte adhesive deficiency syndrome.然而,LFA-1的细胞表面表达的遗传重构恢复了DNAM-1启动抗DNAM-1 MAB诱导的细胞毒性的能力,表明DNAM-1与LFA-1之间的功能关系。进一步的研究表明,LFA-1在NK细胞中与DNAM-1物理相关,抗CD3 MAB刺激的T细胞,DNAM-1的丝氨酸磷酸化起着至关重要的作用。此外,LFA-1的交联诱导DNAM-1的酪氨酸磷酸化,为此,FYN蛋白酪氨酸激酶负责。这些结果表明DNAM-1参与LFA-1介导的细胞内信号。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shibuya, A, et al: "Protein kinase C is involved in the regulation of both signaling and adresion mediated DNAM-1"J. Immunology. 161. 1671-1676 (1998)
Shibuya, A, 等人:“蛋白激酶 C 参与信号传导和邻接介导的 DNAM-1 的调节”J.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shibuya K., Lanier LL., Phillips JH., Ochs D., Shimizu K., Nakayama E., Nakauchi H., Shibuya A.: "Physical and functional association of LFA-1 with DNAM-1 adhesion molecule."Immunity. 11. 615-623 (1999)
Shibuya K.、Lanier LL.、Phillips JH.、Ochs D.、Shimizu K.、Nakayama E.、Nakauchi H.、Shibuya A.:“LFA-1 与 DNAM-1 粘附分子的物理和功能关联。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shibuya A., Lanier LL., Phillips JH.: "Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAM-1 receptor."J. Immunol.. 161. 1671-1676 (1998)
Shibuya A.、Lanier LL.、Phillips JH.:“蛋白激酶 C 参与 DNAM-1 受体介导的信号传导和粘附的调节。”J.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shibuya K.et al.: "Physical and functional association of LFA-1 with DNAM-1 adhesion molecule"Immunity. 11. 615-623 (1999)
Shibuya K.等人:“LFA-1 与 DNAM-1 粘附分子的物理和功能关联”免疫。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shibuya A.et al.: "Protein-kinase C in involved in the regulation of both signaling and adhesion mediated DNAM-1"J. Immunology. 161. 1671-1676 (1998)
Shibuya A.et al.:“蛋白激酶 C 参与信号传导和粘附介导的 DNAM-1 的调节”J.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHIBUYA Akira其他文献
Novel prophylactic and therapeutic approches to GVHD with a monoclonal antibodies against DNAM-1
使用 DNAM-1 单克隆抗体预防和治疗 GVHD 的新方法
- DOI:
- 发表时间:
2009 - 期刊:
- 影响因子:0
- 作者:
KAI Hirayasy;IGUCHI Akiko;WANG Yinan;YAMASHITA Yumi;YASUI Teruhito;KIKUTANI Hitoshi;THARA-HANAOKA Satoko;HONDA Shin-ichiro;SHIBUYA Akira;SHIBUYA Kazuko.;Nabekura T.;鍋倉宰 - 通讯作者:
鍋倉宰
Novel prophylactic and therapeutic approches to GVHD with a monoclonal antobodies against DNAM-1
利用 DNAM-1 单克隆抗体预防和治疗 GVHD 的新方法
- DOI:
- 发表时间:
2009 - 期刊:
- 影响因子:0
- 作者:
KAI Hirayasy;IGUCHI Akiko;WANG Yinan;YAMASHITA Yumi;YASUI Teruhito;KIKUTANI Hitoshi;THARA-HANAOKA Satoko;HONDA Shin-ichiro;SHIBUYA Akira;SHIBUYA Kazuko.;Nabekura T. - 通讯作者:
Nabekura T.
Analysis for the variants of Fcα/μR, a novel Fc receptor for IgA and IgM, expressed in the kidney and testis.
Fcα/μR 变异体的分析,Fcα/μR 是一种新型 IgA 和 IgM Fc 受体,在肾脏和睾丸中表达。
- DOI:
- 发表时间:
2007 - 期刊:
- 影响因子:0
- 作者:
USUI Kenta;HONDA Shin-ichiro;KURITA Naoki;MIYAMOTO Akitomo;CHO Yukiko;TAHARA-HANAOKA Satoko;SHIBUYA Kazuko;SHIBUYA Akira - 通讯作者:
SHIBUYA Akira
SHIBUYA Akira的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHIBUYA Akira', 18)}}的其他基金
Development of the therapy for allergic airway hypersensitivity by using a phospholipid liposome
磷脂脂质体治疗过敏性气道超敏反应的开发
- 批准号:
16K15455 - 财政年份:2016
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
The immunopathological study on leukocyte adhesion molecule DNAM-1 (CD226)
白细胞粘附分子DNAM-1(CD226)的免疫病理学研究
- 批准号:
21249026 - 财政年份:2009
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Development of immunotherapy for DNAM-1 as a molecular target in graft-versus-host disease
DNAM-1 免疫疗法作为移植物抗宿主病分子靶标的开发
- 批准号:
19390257 - 财政年份:2007
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular base of the defenses against infection by IgM and IgA
IgM 和 IgA 感染防御的分子基础
- 批准号:
16017215 - 财政年份:2004
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Analysis of Mucosal Immunity by the Fc receptor for IgA and IgM
IgA 和 IgM Fc 受体的粘膜免疫分析
- 批准号:
14207024 - 财政年份:2002
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
ANALYSIS OF IMMUNE REGULATION BY ADHESION MOLECULE COMPLEX ON KILLER LYMPHOCYTES
粘附分子复合物对杀伤淋巴细胞免疫调节的分析
- 批准号:
12470111 - 财政年份:2000
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似国自然基金
施旺细胞来源的粘附分子L1负调控脊髓运动神经元cGAS-STING促进臂丛撕脱运动功能恢复的机制研究
- 批准号:82301581
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
粘附分子IGSF11调控小鼠初级精母细胞发育的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
粘附分子IGSF11调控小鼠初级精母细胞发育的机制研究
- 批准号:32200705
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
核酸聚合物细胞粘附分子抑制剂用于肿瘤转移治疗研究
- 批准号:22174038
- 批准年份:2021
- 资助金额:60.00 万元
- 项目类别:面上项目
核酸聚合物细胞粘附分子抑制剂用于肿瘤转移治疗研究
- 批准号:
- 批准年份:2021
- 资助金额:60 万元
- 项目类别:面上项目
相似海外基金
Molecular mechanisms regulating LMO2+ metastasis initiating cells
调节LMO2转移起始细胞的分子机制
- 批准号:
10659840 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Resident Memory T cells in Chronic Kidney Disease
慢性肾脏病中的常驻记忆 T 细胞
- 批准号:
10676628 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Developing novel therapies to improve blood stem cell transplantation outcomes
开发新疗法以改善造血干细胞移植结果
- 批准号:
10830194 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Investigating a novel role of DRAK2 in T cell migration and synapse formation
研究 DRAK2 在 T 细胞迁移和突触形成中的新作用
- 批准号:
10680274 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Endothelial-Leukocyte Adhesion in CAR T Cell Treatment Associated Neurotoxicity
CAR T 细胞治疗相关神经毒性中的内皮-白细胞粘附
- 批准号:
10735681 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别: